DR. LAL PATHLABS LIMITED Business Segments Dr. Lal PathLabs Limited
Equities
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,342.90 INR | -1.15% |
|
-1.06% | +29.69% |
| Aug. 12 | Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,720 From INR2,713, Keeps at Buy | MT |
| Aug. 08 | Dr. Lal PathLabs' Consolidated Net Profit Shows Growth in Fiscal Q1 | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Laboratory Services | ||||||||||
Running Laboratories | 13.3B | 15.81B | 20.87B | 20.17B | 22.27B | |||||
Total Assets | 13.74B | 16.61B | 23.53B | 23.86B | 24.56B | |||||
Interest Expense | -153M | -160M | -302M | -375M | -294M | |||||
Income Tax Expense | 829M | 979M | 1.25B | 1.03B | 1.43B | |||||
CAPEX | -796M | -596M | -4.76B | -365M | -512M | |||||
EBT | 3.11B | 3.94B | 4.75B | 3.44B | 5.05B | |||||
D&A | 663M | 701M | 1.01B | 1.43B | 1.37B | |||||
Net Income | 2.26B | 2.92B | 3.45B | 2.39B | 3.58B |
Geographical Revenue Distribution History
| Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 13.17B | 15.71B | 20.73B | 19.95B | 22.01B | |||||
Total Assets | 4.21B | 4.74B | 14.16B | 13.28B | 12.45B | |||||
Outside India | 130M | 104M | 140M | 220M | 259M | |||||
Total Assets | 46.3M | 72.65M | - | 37.16M | 65.04M |
- Stock Market
- Equities
- LALPATHLAB Stock
- Financials Dr. Lal PathLabs Limited
- Business Segments